PL2768308T3 - Związki i substraty przeciwnowotworowe nqo1 - Google Patents

Związki i substraty przeciwnowotworowe nqo1

Info

Publication number
PL2768308T3
PL2768308T3 PL12840771T PL12840771T PL2768308T3 PL 2768308 T3 PL2768308 T3 PL 2768308T3 PL 12840771 T PL12840771 T PL 12840771T PL 12840771 T PL12840771 T PL 12840771T PL 2768308 T3 PL2768308 T3 PL 2768308T3
Authority
PL
Poland
Prior art keywords
tumor
compounds
nqo1
substrates
nqo1 substrates
Prior art date
Application number
PL12840771T
Other languages
English (en)
Inventor
Paul J. Hergenrother
David A. Boothman
Joseph S. BAIR
Rahul Palchaudhuri
Original Assignee
The Board Of Trustees Of The University Of Illinois
The Board Of Regents Of The University Of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Board Of Trustees Of The University Of Illinois, The Board Of Regents Of The University Of Texas System filed Critical The Board Of Trustees Of The University Of Illinois
Publication of PL2768308T3 publication Critical patent/PL2768308T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL12840771T 2011-10-14 2012-10-12 Związki i substraty przeciwnowotworowe nqo1 PL2768308T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161547166P 2011-10-14 2011-10-14
US201261662163P 2012-06-20 2012-06-20
PCT/US2012/059988 WO2013056073A1 (en) 2011-10-14 2012-10-12 Compounds and anti-tumor nqo1 substrates
EP12840771.5A EP2768308B8 (en) 2011-10-14 2012-10-12 Compounds and anti-tumor nqo1 substrates

Publications (1)

Publication Number Publication Date
PL2768308T3 true PL2768308T3 (pl) 2018-12-31

Family

ID=48082500

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12840771T PL2768308T3 (pl) 2011-10-14 2012-10-12 Związki i substraty przeciwnowotworowe nqo1

Country Status (10)

Country Link
US (4) US9233960B2 (pl)
EP (1) EP2768308B8 (pl)
CA (1) CA2887648C (pl)
DK (1) DK2768308T3 (pl)
ES (1) ES2678649T3 (pl)
HU (1) HUE039247T2 (pl)
PL (1) PL2768308T3 (pl)
PT (1) PT2768308T (pl)
TR (1) TR201810152T4 (pl)
WO (1) WO2013056073A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2909091C (en) 2013-04-09 2021-11-02 The Board Of Trustees Of The University Of Illinois Tumor-selective combination therapy
WO2015142952A1 (en) 2014-03-17 2015-09-24 The Board Of Trustees Of The University Of Illinois Compounds for treatment of fluorquinolone-resistant bacteria
WO2017108339A1 (en) 2015-12-21 2017-06-29 Dsm Ip Assets B.V. Intermolecular reaction of propargyl ethers with dimethylfuran in the presence of gold(i) complexes
WO2017156519A1 (en) 2016-03-11 2017-09-14 The Board Of Trustees Of The University Of Illinois Small-molecules active against gram-negative bacteria
EA201892834A1 (ru) * 2016-06-27 2019-07-31 Системс Онколоджи, Ллс Комбинированная химиотерапия
US11274106B2 (en) 2017-06-23 2022-03-15 The Board Of Trustees Of The University Of Illinois Topoisomerase inhibitors with antibacterial and anticancer activity
WO2019113345A1 (en) * 2017-12-06 2019-06-13 Spyro Mousses Combination of cancer therapeutics for treatment of cancer and hyperproliferative diseases
JP7406300B2 (ja) * 2018-11-12 2023-12-27 信越化学工業株式会社 ヨウ素含有ケイ素化合物の製造方法
CN109485646A (zh) * 2018-12-12 2019-03-19 中国药科大学 一种苯并噻唑醌类化合物及其制备方法和用途
WO2025047770A1 (ja) * 2023-08-31 2025-03-06 東レ株式会社 デオキシニボキノン誘導体の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906562A (en) 1984-12-21 1990-03-06 Oncogen Monocolonal antibodies and antigen for human non-small cell lung carcinomas
ES2088822B1 (es) 1994-02-24 1997-08-01 Univ Madrid Complutense Nuevos derivados antraquinonicos con actividad antitumoral y sus aplicaciones.
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6924312B2 (en) 2001-07-10 2005-08-02 Synta Pharmaceuticals Corp. Taxol enhancer compounds
NO2619331T3 (pl) * 2010-09-22 2018-07-28
GB201021494D0 (en) * 2010-12-20 2011-02-02 Univ Cardiff Compounds

Also Published As

Publication number Publication date
WO2013056073A1 (en) 2013-04-18
EP2768308A1 (en) 2014-08-27
PT2768308T (pt) 2018-07-24
EP2768308B8 (en) 2018-08-01
US9925180B2 (en) 2018-03-27
US20180207150A1 (en) 2018-07-26
CA2887648A1 (en) 2013-04-18
ES2678649T3 (es) 2018-08-14
US9233960B2 (en) 2016-01-12
US20150011509A1 (en) 2015-01-08
CA2887648C (en) 2020-01-21
HUE039247T2 (hu) 2018-12-28
US20170182030A1 (en) 2017-06-29
US9611266B2 (en) 2017-04-04
TR201810152T4 (tr) 2018-08-27
US20160122348A1 (en) 2016-05-05
EP2768308B1 (en) 2018-04-18
US10285986B2 (en) 2019-05-14
DK2768308T3 (en) 2018-07-23
EP2768308A4 (en) 2015-06-17

Similar Documents

Publication Publication Date Title
HRP20190681T1 (hr) Premazivanje ploče
GB2481187B (en) Processing substrates
SG10201401901WA (en) Glass for substrate, and glass substrate
PL2668350T3 (pl) Panel
PL2675768T3 (pl) Przepust
EP2736330A4 (en) COMPOUNDS AND METHODS
HUE051418T2 (hu) Átvezetés
HUE039247T2 (hu) Vegyületek és tumorellenes NQO1-szubsztrátok
IL231351A (en) Imidazopyridazines are conserved in amino acids
EP2747560A4 (en) CONNECTIONS AND METHODS
EP2736332A4 (en) CONNECTIONS AND METHODS
ZA201308021B (en) Antiballistic panel
EP2736329A4 (en) COMPOUNDS AND METHODS
GB2491217B (en) Multilayer substrate
PL2678331T3 (pl) Pochodne diaminopirymidyny i sposoby ich wytwarzania
EP2728087A4 (en) FIXING ATTACHMENT FOR PANEL
TWI560292B (en) Deposition source and deposition apparatus including the same
GB201120660D0 (en) Panels
SG11201403501PA (en) Composite substrate
EP2707598A4 (en) PLASMA MICRO-THRUSTER
HUP1400149A2 (en) Packaging for substrates and packaging unit having such packaging
SG2014013213A (en) Substrate rollers
IL236882A0 (en) Diamond coating and method for its preparation
GB201111775D0 (en) Compounds and uses thereof
GB201112721D0 (en) Antimalarial